相关实验视频
Updated: Sep 19, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
耐火细分性质血管炎用Janus激酶抑制剂托法西提尼布治疗:一个病例报告
Yue Zhang1, Rushan Xia1,2
1Department of Dermatology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, People's Republic of China.
托法西替尼 (tofacitinib) 有效地治疗了患有细分性氨酸血管炎的患者,解决了皮肤病变. 这一案例突出了托法西提尼布作为这种罕见的血管炎的潜在治疗方法.
科学领域:
- 皮肤病学 皮肤病学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 分段性氨酸血管炎是一种罕见的疾病.
- 血管炎可以引起显著的皮肤表现.
更多相关视频
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
12:40A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
相关概念视频
The JAK-STAT Signaling Pathway
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Nephrotic Syndrome II : Assessment and Medical Management
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Rheumatic Heart Disease III: Medical Management
Nephrotic Syndrome I : Introduction